On December 30, 2023, Cachet Pharmaceutical (002462.SZ) announced that on December 30, 2024, the company will hold its third extraordinary general meeting of shareholders for 2024, during which the proposal for the election of a non-independent director was approved, and Mr. Xu Xi officially became a non-independent director of the seventh Board of Directors. On the same day, the company held its fourteenth extraordinary meeting of the seventh Board of Directors, where the proposal for the election of the company's chairman was approved, electing Mr. Xu Xi as the company's chairman. According to the provisions of the Articles of Association, Mr. Xu Xi also serves as the legal representative of the company, with a term from the day the Board of Directors approved it until the end of the current Board of Directors' term.